All Stories

Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs

Merely a minute into his prepared remarks during Jazz Pharmaceuticals’ fourth-quarter earnings call, CEO Bruce Cozadd brought investors’ attention to the company’s appetite in dealmaking.

Feb 26, 2025 - 17:13
 0
Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs
Merely a minute into his prepared remarks during Jazz Pharmaceuticals’ fourth-quarter earnings call, CEO Bruce Cozadd brought investors’ attention to the company’s appetite in dealmaking.
Read More

Tags:

Previous Article

DHL sells 91-year-old Midwest LTL carrier

Next Article

AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch

Related Posts

Gilead sets aside $200M for potential settlement over HIV drug speaker program

Gilead sets aside $200M for potential settlement over H...

Mar 4, 2025  0

Sanofi signs up Chrissy Teigen for diabetes screening campaign

Sanofi signs up Chrissy Teigen for diabetes screening c...

Apr 15, 2025  0

Roche gains label expansion for heart attack medicine TNKase to treat acute ischemic stroke

Roche gains label expansion for heart attack medicine T...

Mar 3, 2025  0